NC Emerge® H7493926712370Recalls & reported problems
Boston Scientific Corporation · PTCA Dilatation Catheter · Class 2
All models of NC Emerge (61)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 08714729846420), received between Sep 23, 2019 and Jan 4, 2023 — classified as 4 malfunctions.
The most frequently reported specific device problem is “Break” (4 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Break4
- Material Deformation2
Patient problems
- No Clinical Signs, Symptoms or Conditions2
- No Consequences Or Impact To Patient2
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
MalfunctionJan 4, 2023Break; Material Deformation; Break; Material Deformation
IT WAS REPORTED THAT SHAFT BREAK OCCURRED. THE PATIENT WAS PRESENTED WITH CARDIOVASCULAR ARTERY DISEASE AND UNDERWENT PERCUTANEOUS CORONARY INTERVENTION. THE 90% STENOSED TARGET LESION WAS LOCATED IN MODERATE TO SEVERELY CALCIFIED AND TORTUOUS LEFT ANTERIOR DESCENDING ARTERY (LAD) AS WELL AS RADIAL ARTERY. A 3.75MM X 12MM, 3.75MM X 20MM, 3.75MM X 12MM, AND 3.75MM X 15MM NC EMERGE BALLOON CATHETERS WERE USED. HOWEVER, THE SHAFT OF THE FOUR CATHETERS WERE BADLY BENT AND BROKEN. THE DEVICES WERE BOTH PULLED OUT INTACT FROM THE PATIENT'S BODY. THE PROCEDURE WAS COMPLETED WITH DIFFERENT BALLOON. THERE WERE NO PATIENT COMPLICATIONS REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 16096552 ↗MalfunctionJan 3, 2023Break; Material Deformation; Break; Material Deformation
IT WAS REPORTED THAT SHAFT BREAK OCCURRED. THE PATIENT WAS PRESENTED WITH CARDIOVASCULAR ARTERY DISEASE AND UNDERWENT PERCUTANEOUS CORONARY INTERVENTION. THE 90% STENOSED TARGET LESION WAS LOCATED IN MODERATE TO SEVERELY CALCIFIED AND TORTUOUS LEFT ANTERIOR DESCENDING ARTERY (LAD) AS WELL AS RADIAL ARTERY. A 3.75MM X 12MM, 3.75MM X 20MM, 3.75MM X 12MM, AND 3.75MM X 15MM NC EMERGE BALLOON CATHETERS WERE USED. HOWEVER, THE SHAFT OF THE FOUR CATHETERS WERE BADLY BENT AND BROKEN. THE DEVICES WERE BOTH PULLED OUT INTACT FROM THE PATIENT'S BODY. THE PROCEDURE WAS COMPLETED DIFFERENT BALLOON. THERE WERE NO PATIENT COMPLICATIONS REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 16090927 ↗MalfunctionDec 13, 2019Break; Break
IT WAS REPORTED THAT SHAFT BREAK OCCURRED. A 3.75MM X 12MM NC EMERGE BALLOON CATHETER WAS SELETED FOR USE; HOWEVER, IT WAS NOTED THAT THE BALLOON DELIVERY SHAFT, NEAR THE HUB WAS FRACTURED. THE PROCEDURE WAS COMPLETED WITH ANOTHER OF THE SAME DEVICE.NO PATIENT COMPLICATIONS WERE REPORTED AND THE PATIENT'S STATUS WAS STABLE.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 9468127 ↗MalfunctionSep 23, 2019Break; Break
IT WAS REPORTED THAT SHAFT BREAK OCCURRED. A 3.75MM X 12MM NC EMERGE BALLOON CATHETER AND A 6MMX3.25MM WOLVERINE BALLOON CATHETER WERE SELECTED FOR USE. HOWEVER, DURING PROCEDURE, THE SHAFTS WERE SNAPPED WHEN ATTEMPTED TO CROSS THE LESION. THE PROCEDURE WAS COMPLETED WITH A DIFFERENT DEVICE. NO PATIENT COMPLICATIONS WERE REPORTED AND THE PATIENT WAS FINE.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 9106562 ↗
Other Catheters, transluminal coronary angioplasty, percutaneous devices
- MINI TREK™ 1012270-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous223 reports
- Maverick²™ H7493892815200Boston Scientific Corporation · Catheters, transluminal coronary angioplasty, percutaneous1 death203 reports
- MINI TREK™ 1012270-12Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous162 reports
- Maverick²™ H7493892820200Boston Scientific Corporation · Catheters, transluminal coronary angioplasty, percutaneous161 reports
- NC TREK 1012454-08Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous2 recalls59 reports
- TREK™ 1012272-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous2 deaths158 reports
- NC TREK 1012453-12Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous1 recall84 reports
- NC TREK 1012453-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous1 recall1 death83 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page